Literature DB >> 23613224

Home-based versus hospital-based high-intensity interval training in cardiac rehabilitation: a randomized study.

Inger-Lise Aamot1, Siv Hege Forbord2, Kjersti Gustad3, Vibeke Løckra2, Andreas Stensen3, Astrid Tarlebø Berg2, Håvard Dalen4, Trine Karlsen5, Asbjørn Støylen6.   

Abstract

BACKGROUND: High-intensity interval training (HIT) as exercise therapy is gradually implemented in cardiac rehabilitation as the cardiovascular benefits from exercise is intensity dependent. However, in previous studies, HIT has been performed with strict supervision. The aim of the study was to assess the feasibility and effectiveness of different modes of HIT in cardiac rehabilitation.
DESIGN: a randomized clinical study.
METHODS: Ninety participants with coronary artery disease (80 men/10 women, mean age 57 ± 8 years) were randomly assigned to one of three exercise modes: group exercise (GE), treadmill exercise (TE), or home-based exercise (HE). HIT was performed twice a week for 12 weeks with an exercise intensity of 85-95% of peak heart rate. The primary outcome measure was change in peak oxygen uptake (peak VO2).
RESULTS: Eighty-three participants (92%) completed the intervention without any severe adverse events. Peak VO2 increased from 34.7 ± 7.3 to 39.0 ± 8.0 ml/kg/min, 32.7 ± 6.5 to 36.0 ± 6.2 ml/kg/min, and 34.4 ± 4.8 to 37.2 ± 5.2 ml/kg/min in TE, GE, and HE, respectively. Mean group difference for TE vs. HE was 1.6 ml/kg/min (95% confidence interval, CI, 0.7 to 3.1, p = 0.02), TE vs. GE 1.1 ml/kg/min (95% CI-0.5 to 2.5, p = 0.27), and GE vs. HE 0.6 ml/kg/min (95% CI -1.0 to 2.1, p = 1). However, on-treatment analysis showed no significant difference between groups.
CONCLUSION: HIT was efficiently performed in three settings of cardiac rehabilitation, with respect to target exercise intensity, exercise attendance, and increase in peak VO2. Exercise mode was not essential for exercise capacity.
© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Cardiac rehabilitation; exercise attendance; feasibility; high-intensity interval training; home-based exercise; quality of life

Mesh:

Year:  2013        PMID: 23613224     DOI: 10.1177/2047487313488299

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  21 in total

1.  Home-Based Cardiac Rehabilitation: A SCIENTIFIC STATEMENT FROM THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION, THE AMERICAN HEART ASSOCIATION, AND THE AMERICAN COLLEGE OF CARDIOLOGY.

Authors:  Randal J Thomas; Alexis L Beatty; Theresa M Beckie; LaPrincess C Brewer; Todd M Brown; Daniel E Forman; Barry A Franklin; Steven J Keteyian; Dalane W Kitzman; Judith G Regensteiner; Bonnie K Sanderson; Mary A Whooley
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-07       Impact factor: 2.081

2.  Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.

Authors:  Randal J Thomas; Alexis L Beatty; Theresa M Beckie; LaPrincess C Brewer; Todd M Brown; Daniel E Forman; Barry A Franklin; Steven J Keteyian; Dalane W Kitzman; Judith G Regensteiner; Bonnie K Sanderson; Mary A Whooley
Journal:  J Am Coll Cardiol       Date:  2019-05-13       Impact factor: 24.094

Review 3.  Home-based versus centre-based cardiac rehabilitation.

Authors:  Lindsey Anderson; Georgina A Sharp; Rebecca J Norton; Hasnain Dalal; Sarah G Dean; Kate Jolly; Aynsley Cowie; Anna Zawada; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-06-30

4.  An Internet- and mobile-based tailored intervention to enhance maintenance of physical activity after cardiac rehabilitation: short-term results of a randomized controlled trial.

Authors:  Konstantinos Antypas; Silje C Wangberg
Journal:  J Med Internet Res       Date:  2014-03-11       Impact factor: 5.428

5.  Protocol for the PREHAB study-Pre-operative Rehabilitation for reduction of Hospitalization After coronary Bypass and valvular surgery: a randomised controlled trial.

Authors:  Andrew N Stammers; D Scott Kehler; Jonathan Afilalo; Lorraine J Avery; Sean M Bagshaw; Hilary P Grocott; Jean-Francois Légaré; Sarvesh Logsetty; Colleen Metge; Thang Nguyen; Kenneth Rockwood; Jitender Sareen; Jo-Ann Sawatzky; Navdeep Tangri; Nicholas Giacomantonio; Ansar Hassan; Todd A Duhamel; Rakesh C Arora
Journal:  BMJ Open       Date:  2015-03-09       Impact factor: 2.692

6.  A pilot study examining the effects of low-volume high-intensity interval training and continuous low to moderate intensity training on quality of life, functional capacity and cardiovascular risk factors in cancer survivors.

Authors:  Kellie Toohey; Kate L Pumpa; Leonard Arnolda; Julie Cooke; Desmond Yip; Paul S Craft; Stuart Semple
Journal:  PeerJ       Date:  2016-10-20       Impact factor: 2.984

7.  Is Home-Based, High-Intensity Interval Training Cycling Feasible and Safe for Patients With Knee Osteoarthritis?: Study Protocol for a Randomized Pilot Study.

Authors:  Justin W L Keogh; Josephine Grigg; Christopher J Vertullo
Journal:  Orthop J Sports Med       Date:  2017-03-13

8.  Interventions to promote patient utilisation of cardiac rehabilitation.

Authors:  Carolina Santiago de Araújo Pio; Gabriela Ss Chaves; Philippa Davies; Rod S Taylor; Sherry L Grace
Journal:  Cochrane Database Syst Rev       Date:  2019-02-01

9.  Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study.

Authors:  Jos J Kraal; Niels Peek; M Elske van den Akker-Van Marle; Hareld M C Kemps
Journal:  BMC Cardiovasc Disord       Date:  2013-10-08       Impact factor: 2.298

10.  Peak oxygen uptake after cardiac rehabilitation: a randomized controlled trial of a 12-month maintenance program versus usual care.

Authors:  Erik Madssen; Ingerid Arbo; Ingrid Granøien; Liv Walderhaug; Trine Moholdt
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.